Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Verheyen, N; Auer, J; Bonaros, N; Buchacher, T; Dalos, D; Grimm, M; Mayr, A; Rab, A; Reinstadler, S; Scherr, D; Toth, GG; Weber, T; Zach, DK; Zaruba, MM; Zimpfer, D; Rainer, PP; Pölzl, G.
Austrian consensus statement on the diagnosis and management of hypertrophic cardiomyopathy.
Wien Klin Wochenschr. 2024; 136(Suppl 15): 571-597. Doi: 10.1007/s00508-024-02442-1 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Leading authors Med Uni Graz

Verheyen Nicolas Dominik

Co-authors Med Uni Graz

Rainer Peter

Scherr Daniel

Toth-Gayor Gabor

Zach David

Zimpfer Daniel

Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:

Hypertrophic cardiomyopathy (HCM) is the most common inherited heart disease that is characterized by left ventricular hypertrophy unexplained by secondary causes. Based on international epidemiological data, around 20,000-40,000 patients are expected to be affected in Austria. Due to the wide variety of clinical and morphological manifestations the diagnosis can be difficult and the disease therefore often goes unrecognized. HCM is associated with a substantial reduction in quality of life and can lead to sudden cardiac death, especially in younger patients. Early and correct diagnosis, including genetic testing, is essential for comprehensive counselling of patients and their families and for effective treatment. The latter is especially true as an effective treatment of outflow tract obstruction has recently become available in the form of a first in class cardiac myosin ATPase inhibitor, as a noninvasive alternative to established septal reduction therapies. The aim of this Austrian consensus statement is to summarize the recommendations of international guidelines with respect to the genetic background, pathophysiology, diagnostics and management in the context of the Austrian healthcare system and resources, and to present them in easy to understand algorithms.

Find related publications in this database (using NLM MeSH Indexing)

Austria - administration & dosage

Humans - administration & dosage

Cardiomyopathy, Hypertrophic - therapy, diagnosis

Cardiology - standards

Practice Guidelines as Topic - administration & dosage

Genetic Testing - administration & dosage

Find related publications in this database (Keywords)

Hypertrophic phenotype

Left ventricular outflow tract obstruction

Sudden cardiac death

Phenocopies

Heart failure

© Med Uni Graz • Imprint